Varma Mutual Pension Insurance Co Acquires Shares of 62,000 The Allstate Corporation $ALL

Varma Mutual Pension Insurance Co purchased a new stake in The Allstate Corporation (NYSE:ALL - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 62,000 shares of the insurance provider's stock, valued at approximately $14,752,000.

A number of other large investors have also added to or reduced their stakes in ALL. MV Capital Management Inc. bought a new stake in shares of Allstate during the 4th quarter valued at $25,000. Gables Capital Management Inc. acquired a new position in Allstate in the second quarter valued at about $26,000. Navalign LLC acquired a new position in Allstate in the fourth quarter valued at about $27,000. Kelleher Financial Advisors bought a new stake in Allstate during the second quarter worth about $28,000. Finally, Evolution Wealth Management Inc. grew its stake in Allstate by 7,000.0% during the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider's stock worth $29,000 after buying an additional 140 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ALL shares. UBS Group upped their price target on shares of Allstate from $261.00 to $275.00 and gave the stock a "neutral" rating in a report on Monday, August 10th. Wells Fargo & Company downgraded Allstate from an "equal weight" rating to an "underweight" rating and raised their target price for the company from $243.00 to $250.00 in a report on Friday, August 7th. Wall Street Zen upgraded Allstate from a "hold" rating to a "buy" rating in a research note on Monday, July 20th. Roth Capital set a $300.00 price target on Allstate in a report on Thursday, August 6th. Finally, Cantor Fitzgerald upped their price objective on Allstate from $236.00 to $242.00 and gave the stock a "neutral" rating in a research report on Thursday, July 9th. Four equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have assigned a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $265.26.

Allstate News Summary

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Allstate Stock Down 0.0%

Shares of ALL opened at $253.82 on Monday. The Allstate Corporation has a 52 week low of $188.08 and a 52 week high of $277.22. The stock has a market capitalization of $64.18 billion, a price-to-earnings ratio of 5.07, a PEG ratio of 0.39 and a beta of 0.16. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.36 and a current ratio of 0.36. The stock has a fifty day moving average of $250.34 and a 200-day moving average of $225.12.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, beating the consensus estimate of $6.06 by $2.93. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The company had revenue of $18.60 billion for the quarter, compared to the consensus estimate of $15.46 billion. During the same quarter last year, the business posted $5.94 EPS. Allstate's revenue for the quarter was up 11.8% on a year-over-year basis. As a group, sell-side analysts anticipate that The Allstate Corporation will post 34.45 earnings per share for the current fiscal year.

Allstate Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Monday, August 31st will be paid a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Monday, August 31st. Allstate's dividend payout ratio (DPR) is presently 8.63%.

Insider Transactions at Allstate

In related news, Director Andrea Redmond sold 2,225 shares of the firm's stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the transaction, the director owned 2,225 shares in the company, valued at $451,474.75. This trade represents a 50.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John E. Dugenske sold 32,996 shares of Allstate stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the sale, the insider owned 13,054 shares in the company, valued at approximately $3,515,833.82. This represents a 71.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 91,446 shares of company stock worth $24,208,675. Insiders own 1.55% of the company's stock.

Allstate Company Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source